Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × Imatinib Mesylate × Clear all

NCT02303899 2021-01-22

Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant